Literature DB >> 10486698

Effect of angiotensin-converting enzyme gene polymorphism on left ventricular remodeling after anteroseptal infarction.

J Nagashima1, H Musha, T So, T Kunishima, S Nobuoka, M Murayama.   

Abstract

BACKGROUND AND HYPOTHESIS: Genetic influence on cardiac remodeling is uncertain. The purpose of this study is to determine the effects of polymorphism of the angiotensin-converting enzyme (ACE) gene on cardiac remodeling after myocardial infarction.
METHODS: The subjects were 43 patients with old anteroseptal myocardial infarction. Based on the polymorphism of the ACE gene, they were classified into a deletion group of 25 patients (D/D genotype in 4 and D/I genotype in 21) and an insertion group of 18 patients (all I/I genotype). Echocardiograms were used to determine left ventricular end-diastolic and end-systolic diameters, interventricular septal and posterior wall thicknesses, left ventricular mass, left atrial diameter, and left ventricular ejection fraction. Blood concentrations of atrial and brain natriuretic peptide were also measured.
RESULTS: Left ventricular end-systolic and end-diastolic dimensions, left ventricular mass, and levels of both atrial and brain natriuretic peptide were significantly higher in the deletion group. In contrast, septal thickness, posterior wall thickness, and ejection fraction showed no differences between the two groups.
CONCLUSIONS: In patients with old anteroseptal infarction, ACE gene polymorphism of the D/D and D/I genotypes has a stronger influence on left ventricular remodeling than polymorphism of the I/I genotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486698      PMCID: PMC6656168          DOI: 10.1002/clc.4960220909

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  26 in total

1.  Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group.

Authors:  J Kjekshus; K Swedberg; S Snapinn
Journal:  Am J Cardiol       Date:  1992-01-01       Impact factor: 2.778

2.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

Authors:  L E Teichholz; T Kreulen; M V Herman; R Gorlin
Journal:  Am J Cardiol       Date:  1976-01       Impact factor: 2.778

3.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

4.  Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension.

Authors:  X Jeunemaitre; R P Lifton; S C Hunt; R R Williams; J M Lalouel
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

5.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

6.  Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene.

Authors:  C Hubert; A M Houot; P Corvol; F Soubrier
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

7.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

8.  Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension.

Authors:  R Y Zee; Y K Lou; L R Griffiths; B J Morris
Journal:  Biochem Biophys Res Commun       Date:  1992-04-15       Impact factor: 3.575

9.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.

Authors:  L Tiret; B Rigat; S Visvikis; C Breda; P Corvol; F Cambien; F Soubrier
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

10.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

View more
  7 in total

1.  Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy.

Authors:  R Panovsky; A Vasku; J Meluzin; M Kaminek; J Mayer; S Janousek; V Kincl; L Groch; M Navratil
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

2.  Gene polymorphisms and thyroid function in patients with heart failure.

Authors:  Ioannis Vasiliadis; Genovefa Kolovou; Vana Kolovou; Vasiliki Giannakopoulou; Maria Boutsikou; Niki Katsiki; Evaggelia Papadopoulou; Sophie Mavrogeni; Konstantina Sorontila; Costas Pantos; Dennis V Cokkinos
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

Review 3.  Structural aspects of Golgi function.

Authors:  R S Polishchuk; A A Mironov
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

4.  ACE gene insertion/deletion polymorphism has a mild influence on the acute development of left ventricular dysfunction in patients with ST elevation myocardial infarction treated with primary PCI.

Authors:  Jiri Parenica; Monika Pavkova Goldbergova; Petr Kala; Jiri Jarkovsky; Martin Poloczek; Jan Manousek; Krystyna Prymusova; Lenka Kubkova; Daniela Tomcikova; Ondrej Toman; Martin Tesak; Josef Tomandl; Anna Vasku; Jindrich Spinar
Journal:  BMC Cardiovasc Disord       Date:  2010-12-17       Impact factor: 2.298

5.  Influence of Angiotensin-Converting-Enzyme Gene Polymorphism on Echocardiographic Data of Patients with Ischemic Heart Failure.

Authors:  Gustavo Salgado Duque; Dayse Aparecida da Silva; Felipe Neves de Albuquerque; Roberta Siuffo Schneider; Alinne Gimenez; Roberto Pozzan; Ricardo Mourilhe Rocha; Denilson Campos de Albuquerque
Journal:  Arq Bras Cardiol       Date:  2016-10-27       Impact factor: 2.000

6.  Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction.

Authors:  Nagaraja Moorthy; Kalpana Saligrama Ramegowda; Simran Jain; G Bharath; Archana Sinha; Manjunath C Nanjappa; Rita Christopher
Journal:  Int J Cardiol Heart Vasc       Date:  2021-01-01

7.  Association Between ACE Gene Polymorphism and QT Dispersion in Patients with Acute Myocardial Infarction.

Authors:  Zulkuf Karahan; Murat Ugurlu; Berzal Ucaman; Ali Veysel Ulug; Ilyas Kaya; Kemal Cevik; Mehmet Sahin Adiyaman; Onder Oztürk; Hikmet Iyem; Ferit Ozdemir
Journal:  Open Cardiovasc Med J       Date:  2016-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.